Emergent BioSolutions plant in Baltimore begins trials of its plasma-derived therapy for COVID

Retrieved on: 2021-08-29 00:38:57

Tags for this article:

Click the tags to see associated articles and topics

Emergent BioSolutions plant in Baltimore begins trials of its plasma-derived therapy for COVID. View article details on hiswai:

Excerpt

Like monoclonal antibody therapy, Emergent's plasma-derived treatment is meant ... Monoclonal antibodies are the therapy used to treat then-President Donald ...

Article found on: www.baltimoresun.com

View Original Article